Saline infusion sonography and office hysteroscopy to assess endometrial morbidity associated with tamoxifen intake

Gynecologic Oncology

Volumn 86, Issue 3, 2002, Pages 323-329

  Garuti, Giancarlo ^a   Cellani, Fulvia ^a   Grossi, Francesco ^a   Colonnelli, Monica ^a   Centinaio, Giovanna ^a   Luerti, Massimo ^a  

^a Lodi Hospital   (Italy)

Author keywords

Breast cancer; Endometrial cancer; Hysteroscopy; Saline infusion sonography; Sonohysterography; Tamoxifen; Transvaginal ultrasonography

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BLEEDING; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; ENDOMETRITIS; ENDOMETRIUM; ENDOMETRIUM BIOPSY; FEASIBILITY STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; HYSTEROSCOPY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MORBIDITY; MYOMA; PATHOLOGY; PATIENT ATTITUDE; PELVIS PAIN SYNDROME; POLYP; POSTMENOPAUSE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; SYNCOPE; TRANSVAGINAL ECHOGRAPHY; UTERUS PERFORATION;

EID: 0036445490     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2002.6783     Document Type: Article

References (34)

1. FIGO annual report on the results of treatment in gynecological cancer, Vol 24. J Epidemiol Biostatistics 2001;6:45-86.
2. Creutzberg CL, VariPutten WLJ, Koper PC, et al. Surgery and postoperative radiotherapy vs surgery alone for patients with stage I endometrial carcinoma: Multicentric randomized trial. Lancet 2000;355:1404-11.
3. Pustilnik T, Burke T. Adjuvant chemotherapy for high risk endometrial cancer. Semin Rad Oncol 2000;10:23-8.
4. Morrow CP, Curtin JP. Management of uterine neoplasias. In: Mitchell J, Hardy J, Birch DJ, editors. Gynecologic Cancer Surgery. New York: Churchill Livingstone, 1996;569-625.
5. Gerber B, Krouse A, Muller H, Reimer T, Kulz T, Makovitzky J, Kundt G, Friese K. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: A prospective long-term study using transvaginal ultrasound. J Clin Oncol 2000;18:3464-70.
6. Fisher B, Costantino GP, Redmond CK, Fisher ER, Wickerham DL, Cronin VM. Endometrial cancer in tamoxifen-treated patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 1994;86:527-37.
7. Stearns V, Gelmann EP. Does tamoxifen cause cancer in humans? J Clin Oncol 1998;16:779-92.
8. Love BB, Muir BB, Scrimgeour JB, Leonard RCF, Dillon P, Dixon JM. Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening. J Clin Oncol 1999;17:2050-54.
9. Barakat RR, Grigsby PW, Sabbatini P, Zaino RJ. In: Hoskins WJ, Perez CA, Young RC, editors. Principle and Practice of Gynecologic Oncology. 3rd Ed. Philadelphia; Lippincott Williams & Wilkins, 2000;919-59.
10. Tesoro MR, Borgida AF, McLaurin NA, Asuncion CM. Transvaginal endometrial sonography in postmenopausal women taking tamoxifen. Obstet Gynecol 1999;93:363-66.
11. Franchi M, Ghezzi F, Donadello N, Zanaboni F, Beretta P, Bolis P. Endometrial thickness in tamoxifen treated patients: An independent predictor of endometrial disease. Obstet Gynecol 1999;93:1004-8.
12. Neven P, Vernaeve H. Guidelines for monitoring patients taking tamoxifen treatment. Drug Safety 2000;22:1-11.
13. Karllson B, Granberg S, Wilkand M. Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding. A nordic multicenter study. Am J Obstet Gynecol 1995;172:1488-94.
14. Osmers R, Volksen N, Schauer T. Vaginography for early detection of endometrial carcinoma? Lancet 1990;335:1569-71.
15. Randolph J, Ying Y, Maier D. Comparison of real-time ultrasonography, hysterosalpingography and laparoscopy/hysteroscopy in the evaluation of uterine abnormalities and tubal patency. Fertil Steril 1986;46:828-32.
16. Dijkhuizen FP, DeVries LD, Mol BW, Brolmann HA, Peters HM, Moret E, Heintz AP. Comparison of transvaginal ultrasonography and saline infusion sonography for the detection of intracavitary abnormalities in premenopausal women. Ultrasound Obstet Gynecol 2000;15:372-6.
17. Timmermann D, Deprest J, Bournet T, Van Der Berghe I, Collins WP, Vergote I. A randomized trial on the use of ultrasonography at office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen. Am J Obstet Gynecol 1998;179:62-70.
18. Elhelw B, Ghorab MNM, Farrag SH. Saline sonohysterography for monitoring asymptomatic post-menopausal breast cancer patients taking tamoxifen. Int J Gynecol Obstet 1999;67:81-6.
19. McElrath T, Anderson P, Fields A, Somma L, Gross S, Runowicz C. Saline infusion sonography: A diagnostic and therapeutic intervention for patients on tamoxifen. Obstet Gynecol 2000;95(4S):538-39.
20. Garuti G, Sambruni I, Cellani F, Garzia D, Alleva P, Luerti M. Hysteroscopy and transvaginal ultrasonography in menopausal women with uterine bleeding. Int J Gynecol Obstet 1999;65:23-33.
21. Brooks PG, Serden SP. Hysteroscopic findings after unsuccessful dilatation and curettage for abnormal uterine bleeding. Am J Obstet Gynecol 1988;158:489-92.
22. Gimpelson RJ, Rappold HO. A comparative study between panoramic hysteroscopy with directed biopsies and dilatation and curettage. Am J Obstet Gynecol 1988;158:489-92.
23. Nagele F, O'Connor H, Davies A, Badawy A, Mohamed H, Magos A. 2500 out patient diagnostic hysteroscopies. Obstet Gynecol 1996;88:87-92.
24. Jansen FW, Vredevoogd CB, VanUlzen K, Hermans J, Trimbos JB, Trimbos-Kemper TC. Complications of hysteroscopy: A prospective, multicenter study. Obstet Gynecol 2000;96:266-70.
25. Ceci O, Bettocchi S, Marello F, DiVenere R, Pellegrino AR, Laricchia L, Vimercati A. Hysteroscopic evaluation of the endometrium in postmenopausal women taking tamoxifen. J Am Assoc Gynecol Laparosc 2000;7:185-89.
26. Neven P. Endometrial changes in patients on tamoxifen. The Lancet 1995;346:1292-93.
27. Garuti G, Sambruni I, Colonnelli M, Luerti M. Accuracy of hysteroscopy in predicting histopathology of endometrium in 1500 women. J Am Assoc Gynecol Laparosc 2001;8:207-13.
28. Buckley CH, Fox H. Biopsy pathology of the endometrium. Biopsy Pathology Series 14. London: Chapman & Hall Medical, 1989.
29. Cohen I, Azaria R, Fishman A, Tepper R, Shapira J, Beyth Y. Endometrial cancers in postmenopausal breast cancer patients with tamoxifen treatment. Int J Gynecol Pathol 1999;18:304-9.
30. Bertelli G, Valenzano M, Costantini S, Rissone R, Angiolini C, Signorini A, Gustavino C. Limited value of sonohysterography for endometrial screening in asymptomatic postmenopausal patients treated with tamoxifen. Gynecol Oncol 2000;78:275-77.
31. Hann LE, Gretz EM, Bach AM, Francis SM. Sonohysterography for evaluation of the endometrium in women treated with tamoxifen. Am J Roetgenol 2001;177:337-42.
32. Giorda G, Scarabelli C, Franceschi S, Campagnutta E. Feasibility and pain control in outpatient hysteroscopy in postmenopausal women: A randomized trial. Acta Obstet Gynecol Scand 2000;79:593-97.
33. Garuti G, Grossi F, Cellani F, Centinaio G, Colonnelli M, Luerti M. Hysteroscopic assessment of menopausal breast-cancer patients taking tamoxifen; there is a bias from the mode of endometrial sampling in estimating endometrial morbidity? Breast Cancer Res Treat 2002;72:245-53.
34. Deligdisch L, Cohen CJ, Penault F, Kalir T. Endometrial pathology in 700 patients treated with tamoxifen for breast cancer. Eur J Gynecol Oncol 2001;22(S1):7.